Valproic acid suppresses cervical cancer tumor progression possibly via activating Notch1 signaling and enhances receptor-targeted cancer chemotherapeutic via activating somatostatin receptor type II
Tsai, Cheguo, Leslie, Juliana S., Franko-Tobin, Laura G., Prasnal, Monica C., Yang, Tong, Vienna Mackey, L., Fuselier, Joseph A., Coy, David H., Liu, Mingqiu, Yu, Changyuan, Sun, LichunVolume:
288
Language:
english
Journal:
Archives of Gynecology and Obstetrics
DOI:
10.1007/s00404-013-2762-7
Date:
August, 2013
File:
PDF, 367 KB
english, 2013